| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.057 | 0.3 |